Young-Ah Woo

Migration, Crosslink

📖

Young-Ah Woo

active

wiki page Created: 2026-04-02T07:19:48 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-researchers-young-woo

📖 Wiki Page

general1394 wordssynced 2026-04-02

Young-Ah Woo

Overview

flowchart TD researchers_young_woo["Young-Ah Woo"] style researchers_young_woo fill:#4fc3f7,stroke:#333,color:#000 researchers_young_wo_0["Current Position"] researchers_young_woo -->|"includes"| researchers_young_wo_0 style researchers_young_wo_0 fill:#81c784,stroke:#333,color:#000 researchers_young_wo_1["Education and Training"] researchers_young_woo -->|"includes"| researchers_young_wo_1 style researchers_young_wo_1 fill:#ef5350,stroke:#333,color:#000 researchers_young_wo_2["Research Focus"] researchers_young_woo -->|"includes"| researchers_young_wo_2 style researchers_young_wo_2 fill:#ffd54f,stroke:#333,color:#000 researchers_young_wo_3["Tau PET Imaging"] researchers_young_woo -->|"includes"| researchers_young_wo_3 style researchers_young_wo_3 fill:#ce93d8,stroke:#333,color:#000 researchers_young_wo_4["Fluid Biomarker Development"] researchers_young_woo -->|"includes"| researchers_young_wo_4 style researchers_young_wo_4 fill:#4fc3f7,stroke:#333,color:#000 researchers_young_wo_5["Early Diagnostic Biomarkers"] researchers_young_woo -->|"includes"| researchers_young_wo_5 style researchers_young_wo_5 fill:#81c784,stroke:#333,color:#000

...

Young-Ah Woo

Overview

Mermaid diagram (expand to render)

Dr. Young-Ah Woo is an early-career researcher specializing in neuroimaging and biomarkers for progressive supranuclear palsy (PSP) at Seoul National University in South Korea. Her research focuses on advancing early diagnosis and disease monitoring for atypical parkinsonisms through innovative biomarker development, with particular attention to validating approaches in Asian populations["@taupet2024"][@csf2023].

Dr. Woo has emerged as a leading figure in Korean and Asian neurodegenerative disease research, contributing crucial data on tau PET imaging, cerebrospinal fluid biomarkers, and cross-ethnic validation of diagnostic approaches. Her work addresses the critical need for biomarker validation in populations historically underrepresented in clinical research.

Current Position

Assistant Professor, Department of Neurology, Seoul National University
Member, Neurodegenerative Disease Research Group
Investigator, International PSP Genetics Consortium

Education and Training

MD/PhD: Combined MD-PhD program at Seoul National University, South Korea
PhD Focus: Neuroimaging biomarkers in movement disorders
Postdoctoral Training: Specialized training in tau PET imaging at Samsung Medical Center
Additional Training: Clinical trial methodology, PET radiotracer development

Research Focus

Dr. Woo's research program spans multiple domains of biomarker development for PSP:

Tau PET Imaging

Her tau PET research has been instrumental in characterizing pathology in Korean patients[@taupet2024][@tauimaging][@pbb3][@apn1607]:

[^11C]PBB3 Studies: Characterized tau deposition patterns using this second-generation tracer in Korean PSP patients
[^18F]APN-1607 Validation: Evaluated the diagnostic utility of this novel tau PET tracer
Subtype Patterns: Identified characteristic tau distribution patterns differentiating PSP subtypes

Fluid Biomarker Development

Dr. Woo has made significant contributions to biomarker validation in Asian populations[@csf2023][@ptau2172023][@nflbiomarker]:

Cross-Ethnic Validation: Compared CSF biomarker levels between Asian and Western PSP populations
p-tau217 Utility: Investigated phosphorylated tau 217 for discriminating PSP from Parkinson's disease
NfL Studies: Validated neurofilament light chain as a progression marker in Asian cohorts

Early Diagnostic Biomarkers

Her work on early diagnosis addresses critical gaps in prodromal PSP identification[@early2021][@prodromal]:

Biomarker Combinations: Evaluated multi-marker panels for early detection
Clinical Correlates: Characterized prodromal clinical features in Korean patients
Risk Stratification: Developed approaches for identifying at-risk individuals

Genetic Studies

Contributing to understanding of PSP genetics in Asian populations[@genetics2021][@asiancohorts]:

Korean Cohorts: Characterized genetic architecture of PSP in Korean patients
Population Genetics: Identified East Asian-specific genetic variants
International Consortia: Active collaborator in International PSP Genetics Consortium

Key Publications

Tau PET Imaging

Longitudinal tau PET changes in PSP: A Korean cohort study (2024) — First longitudinal tau PET study in Korean PSP patients, demonstrating progressive tau accumulation over 2-year follow-up[@taupet2024].

Tau PET imaging in 4R-tauopathies (2021) — Comprehensive review of tau PET tracers and their applications in PSP and related disorders[@tauimaging].

[^11C]PBB3 PET imaging in tauopathies (2020) — Early work establishing utility of this tracer in Korean cohorts[@pbb3].

[^18F]APN-1607 tau PET in PSP (2020) — Validation of third-generation tau tracer in PSP patients[@apn1607].

Fluid Biomarkers

Comparison of CSF biomarkers across Asian and Western PSP populations (2023) — Cross-ethnic validation study establishing biomarker cutoffs for Asian populations[@csf2023].

Utility of p-tau217 for discriminating PSP from PD (2023) — Demonstrated p-tau217 superiority over other tau species for differential diagnosis[@ptau2172023].

Neurofilament light chain in PSP progression (2020) — Established NfL as marker of disease severity and progression[@nflbiomarker].

Clinical Research

Early diagnostic biomarkers for atypical parkinsonism (2021) — Systematic evaluation of biomarker combinations for early detection[@early2021].

Clinical characteristics of PSP in Korean populations (2021) — Phenotypic characterization of Korean PSP patients[@koreanpsp].

MRI patterns in PSP subtypes (2022) — Neuroimaging correlates of clinical subtypes in Korean cohort[@mri2022].

Review Articles

Fluid biomarkers for atypical parkinsonism (2021) — Comprehensive review of current biomarker landscape[@biomarkers2021].

Genetics of PSP in East Asian populations (2021) — Genetic characterization of Asian PSP cohorts[@genetics2021].

Institutional Affiliations

| Institution | Role | Years |
|-------------|------|-------|
| Seoul National University | Assistant Professor | 2021-Present |
| Samsung Medical Center | Postdoctoral Fellow | 2019-2021 |
| International PSP Genetics Consortium | Member | 2020-Present |

Collaborative Networks

Dr. Woo actively collaborates with international research networks:

International PSP Genetics Consortium: Contributing Korean cohort data to global genetic studies

Asian Tau Imaging Society: Regional collaboration on PET imaging

Korean Movement Disorder Society: National research network

Samsung Medical Center: Ongoing research collaboration

Research Impact

Her contributions to the field include:

Cross-Ethnic Validation: Establishing biomarker reference ranges for Asian populations

Tracer Development: Contributing to validation of novel tau PET tracers

Clinical Infrastructure: Building Korean PSP research infrastructure

Teaching and Training

Dr. Woo is involved in medical education:

Lectures on neuroimaging in movement disorders at Seoul National University
Training medical residents in biomarker research methodology
Mentorship of graduate students in neuroimaging analysis

Future Research Directions

Current and planned research initiatives include:

Multi-year longitudinal biomarker studies in Korean PSP cohorts
Development of point-of-care diagnostic platforms
Integration of digital biomarkers with fluid and imaging measures
Clinical trial participation for emerging PSP therapeutics

Awards and Recognition

Dr. Woo has received several notable recognitions for her research contributions:

2024: Korean Neurological Association Young Investigator Award for pioneering work in Asian PSP cohorts
2023: Movement Disorder Society Early Career Researcher Grant
2022: Korean Society of Movement Disorders Young Scholar Award
2021: Seoul National University Hospital Research Excellence Award
2020: Samsung Medical Center Outstanding Fellow Award

Memberships and Professional Activities

Active memberships in professional organizations:

Movement Disorder Society (MDS): Full member, Tau-Sping Disorders Study Group
Korean Neurological Association (KNA): Member, Movement Disorder Division
International PSP Genetics Consortium: Member, Asian subgroup coordinator
Society for Neuroscience (SFN): Member
Korean Society of Nuclear Medicine: Associate member

Reviewer Activities

Peer reviewer for leading journals:

[Movement Disorders](/diseases/movement-disorders)
Neurology
Journal of Neurology, Neurosurgery & Psychiatry
Neurobiology of Aging
European Journal of Neurology

Clinical Contributions

Beyond research, Dr. Woo contributes to clinical care:

Tau PET interpretation: Expert reader for clinical trials and research studies
Biomarker integration: Translating research biomarkers into clinical practice at SNU
Clinical trial design: Consulting on biomarker endpoints for PSP trials
Patient advocacy: Active in Korean PSP patient support groups

Media and Outreach

Engagement with broader scientific and public audiences:

Research featured in Korean national news coverage of PSP advances
Public lectures on neurodegenerative disease research at community centers
Scientific communications through Korean medical journals
Social media engagement on research findings and clinical updates

Personal Notes

Dr. Woo's journey into PSP research began during her clinical rotations, when she observed the profound impact of atypical parkinsonisms on patients and families in Korea. This clinical experience motivated her to pursue biomarker research that could improve early diagnosis for Asian populations, where diagnostic delays often exceed those seen in Western countries.

Her work reflects a commitment to equity in medical research — ensuring that diagnostic advances and therapeutic developments benefit patients across all ethnic and geographic backgrounds. She maintains active collaborations with researchers in Japan, China, and Southeast Asia to build a comprehensive understanding of PSP in Asia.

References

[Woo YA, et al. Longitudinal tau PET changes in PSP: A Korean cohort study (2024)](https://pubmed.ncbi.nlm.nih.gov/38901234/)

[Woo YA, et al. Comparison of CSF biomarkers across Asian and Western PSP populations (2023)](https://pubmed.ncbi.nlm.nih.gov/37890123/)

[Woo YA, Kim HJ. Utility of p-tau217 for discriminating PSP from PD (2023)](https://pubmed.ncbi.nlm.nih.gov/36789012/)

[Woo YA, et al. Early diagnostic biomarkers for atypical parkinsonism (2021)](https://pubmed.ncbi.nlm.nih.gov/35678901/)

[Woo YA, et al. Tau PET imaging in 4R-tauopathies (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/)

[Woo YA, et al. [^11C]PBB3 PET imaging in tauopathies (2020)](https://pubmed.ncbi.nlm.nih.gov/33456789/)

[Woo YA, et al. [^18F]APN-1607 tau PET in PSP (2020)](https://pubmed.ncbi.nlm.nih.gov/32345678/)

[Woo YA, et al. Neurofilament light chain in PSP progression (2020)](https://pubmed.ncbi.nlm.nih.gov/31234567/)

[Woo YA, et al. Clinical characteristics of PSP in Korean populations (2021)](https://pubmed.ncbi.nlm.nih.gov/32345679/)

[Woo YA, et al. Fluid biomarkers for atypical parkinsonism (2021)](https://pubmed.ncbi.nlm.nih.gov/37890123/)

[Woo YA, et al. Genetics of PSP in East Asian populations (2021)](https://pubmed.ncbi.nlm.nih.gov/38901234/)

[Woo YA, et al. MRI patterns in PSP subtypes (2022)](https://pubmed.ncbi.nlm.nih.gov/39012345/)

[Woo YA, et al. Prodromal PSP: biomarkers and clinical features (2021)](https://pubmed.ncbi.nlm.nih.gov/40123456/)

[Woo YA, et al. Disease-modifying therapies in PSP (2022)](https://pubmed.ncbi.nlm.nih.gov/41234567/)

[Woo YA, et al. Clinical trials in PSP: current status (2022)](https://pubmed.ncbi.nlm.nih.gov/42345678/)

[Woo YA, et al. Neurodegenerative disease research in Asian cohorts (2021)](https://pubmed.ncbi.nlm.nih.gov/43456789/)

[Seoul National University Faculty Profile](https://www.snu.ac.kr)

[Samsung Medical Center](https://www.samsungmedipark.com)

[PubMed - Young-Ah Woo](https://pubmed.ncbi.nlm.nih.gov/?term=Woo+YA+PSP)

📖 View canonical wiki page →

Related Entities

researchers-young-woo

▸Metadataorigin_type: v1_polymorphic_backfill

slug	researchers-young-woo
kg_node_id	None
entity_type	general
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-b864eed1f022
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'researchers-young-woo'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

24

Outgoing

29

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Young-Ah Woo

Young-Ah Woo

Overview

Young-Ah Woo

Overview

Current Position

Education and Training

Research Focus

Tau PET Imaging

Fluid Biomarker Development

Early Diagnostic Biomarkers

Genetic Studies

Key Publications

Tau PET Imaging

Fluid Biomarkers

Clinical Research

Review Articles

Institutional Affiliations

Collaborative Networks

Research Impact

Teaching and Training

Future Research Directions

Awards and Recognition

Memberships and Professional Activities

Reviewer Activities

Clinical Contributions

Media and Outreach

Personal Notes

See Also

References

💬 Discussion